Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases

被引：34

作者：

Wu, Ning-hua ^{[1
,2
]}

Ye, Yu ^{[1
]}

Wan, Bin-bin ^{[1
]}

Yu, Yuan-dong ^{[3
]}

Liu, Chao ^{[1
]}

Chen, Qing-jie ^{[1
]}

机构：

[1] Hubei Univ Sci & Technol, Hubei Key Lab Diabet & Angiopathy, Xianning 437000, Hubei, Peoples R China

[2] Hubei Univ Sci & Technol, Basic Med Coll, Xianning 437000, Hubei, Peoples R China

[3] Hubei Univ Med, Renmin Hosp, Dept Oncol, Shiyan 442000, Hubei, Peoples R China

来源：

MOLECULAR NEUROBIOLOGY | 2021年 / 58卷 / 11期

基金：

中国国家自然科学基金;

关键词：

Sigma-1; receptor; MAM; Neurodegenerative; SIGMAR1; Target drugs; ENDOPLASMIC-RETICULUM; NEUROTROPHIC FACTOR; MOUSE MODEL; PAIN HYPERSENSITIVITY; NEUROPATHIC PAIN; BRAIN PLASTICITY; RAT MODEL; ACTIVATION; PATHWAY; DYSFUNCTION;

D O I：

10.1007/s12035-021-02524-5

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

The sigma-1 receptor (Sig-1R) is encoded by the SIGMAR1 gene and is a nonopioid transmembrane receptor located in the mitochondrial-associated endoplasmic reticulum membrane (MAM). It helps to locate endoplasmic reticulum calcium channels, regulates calcium homeostasis, and acts as a molecular chaperone to control cell fate and participate in signal transduction. It plays an important role in protecting neurons through a variety of signaling pathways and participates in the regulation of cognition and motor behavior closely related to neurodegenerative diseases. Based on its neuroprotective effects, Sig-1R has now become a breakthrough target for alleviating Alzheimer's disease and other neurodegenerative diseases. This article reviews the most cutting-edge research on the function of Sig-1R under normal or pathologic conditions and target drugs of the sigma-1 receptor in neurodegenerative diseases.

引用

页码：5649 / 5666

页数：18

共 50 条

[11] Sigma-1 Receptor: A Potential Therapeutic Target for Traumatic Brain Injury
Shi, Mingming
Chen, Fanglian
Chen, Zhijuan
Yang, Weidong
Yue, Shuyuan
Zhang, Jianning
Chen, Xin
FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
[12] Role of sigma-1 receptors in neurodegenerative diseases
Linda Nguyen
Lucke-Wold, Brandon P.
Mookerjee, Shona A.
Cavendish, John Z.
Robson, Matthew J.
Scandinaro, Anna L.
Matsumoto, Rae R.
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 127 (01) : 17 - 29
[13] Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases
Niitsu, Tomihisa
Iyo, Masaomi
Hashimoto, Kenji
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (07) : 875 - 883
[14] Sigma-1 receptor and inflammatory pain
Gris, Georgia
Jose Cobos, Enrique
Zamanillo, Daniel
Portillo-Salido, Enrique
INFLAMMATION RESEARCH, 2015, 64 (06) : 377 - 381
[15] Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases
Jia, Jia
Cheng, Jian
Wang, Cheng
Zhen, Xuechu
FRONTIERS IN CELLULAR NEUROSCIENCE, 2018, 12
[16] Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection
Nguyen, Linda
Lucke-Wold, Brandon P.
Mookerjee, Shona
Kaushal, Nidhi
Matsumoto, Rae R.
SIGMA RECEPTORS: THEIR ROLE IN DISEASE AND AS THERAPEUTIC TARGETS, 2017, 964 : 133 - 152
[17] Peeking into Sigma-1 Receptor Functions Through the Retina
Mavlyutov, Timur A.
Guo, Lian-Wang
SIGMA RECEPTORS: THEIR ROLE IN DISEASE AND AS THERAPEUTIC TARGETS, 2017, 964 : 285 - 297
[18] Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative Diseases
Zhemkov, Vladimir
Geva, Michal
Hayden, Michael R.
Bezprozvanny, Ilya
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
[19] Role of Sigma-1 Receptor in Cocaine Abuse and Neurodegenerative Disease
Cai, Yu
Yang, Lu
Niu, Fang
Liao, Ke
Buch, Shilpa
SIGMA RECEPTORS: THEIR ROLE IN DISEASE AND AS THERAPEUTIC TARGETS, 2017, 964 : 163 - 175
[20] Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson's Disease
Siddiqui, Talha
Bhatt, Lokesh Kumar
NEUROCHEMICAL RESEARCH, 2023, 48 (10) : 2925 - 2935

← 1 2 3 4 5 →